| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A71883111 |
| PharmacoGx | BRD-A71883111 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | INTS5 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | RNPS1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | CDC26 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | HACD1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | DNAJC13 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | MAPK9 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | PPM1D | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | ABHD1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | RAB11A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CDK5RAP3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
